Brooks Laboratories Share Price
67.25+2.69 (+4.17%)
-39.92% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
BROOKSNSE
Brooks Laboratories Share Price
67.25+2.69 (+4.17%)
-39.92% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 2% | 11% | 4% |
| - | - | - | 347% |
| -10% | -11% | -18% | -42% |
| -17% | -16% | -6% | 22% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
LAURUSLABS
ZYDUSLIFE
DRREDDY
CIPLA
MANKIND
AUROPHARMA
LUPIN
BROOKS
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,800.5 | ₹425150 Cr | 38.77 | 8.29 | 58.23 | ₹11479 Cr |
| 9,985 | ₹266265 Cr | 91.03 | 34.04 | 128.41 | ₹2568 Cr |
| 4,674.2 | ₹176301 Cr | 83 | 14.04 | 106.21 | ₹2163 Cr |
| 2,330.9 | ₹125352 Cr | 93.56 | 8.17 | 33.94 | ₹889 Cr |
| 1,260.4 | ₹123591 Cr | 27.39 | 9.42 | 62.53 | ₹5040 Cr |
| 1,366.4 | ₹114351 Cr | 40.84 | 11.08 | 59.2 | ₹4196 Cr |
| 1,394.9 | ₹112474 Cr | 38.82 | 10.86 | 52.6 | ₹3879 Cr |
| 2,498 | ₹102315 Cr | 45.62 | 17.23 | 76.26 | ₹1913 Cr |
| 1,701.6 | ₹97757 Cr | 26.33 | 17.95 | 96.84 | ₹3505 Cr |
| 2,035.8 | ₹92007 Cr | 16.64 | 30.95 | 154.35 | ₹5333 Cr |
| 67.25 | ₹191 Cr | 14.42 | -0.61 | 5.03 | ₹25 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹23 Cr | ₹20 Cr | ₹17 Cr | ₹23 Cr | ₹26 Cr | ₹23 Cr | ₹21 Cr | ₹21 Cr | ₹18 Cr | ₹18 Cr | ₹22 Cr | ₹24 Cr | ₹16 Cr | ₹13 Cr | ₹15 Cr | ₹18 Cr | ₹17 Cr | ₹28 Cr | ₹19 Cr | ₹21 Cr | ₹22 Cr | ₹15 Cr | ₹21 Cr | ₹29 Cr |
| ₹18 L | ₹44 L | ₹13 L | ₹39 L | ₹22 L | ₹62 L | ₹3 L | ₹20 L | ₹7 L | ₹65 L | ₹16 L | ₹9 L | ₹6 L | ₹3 L | ₹9 L | ₹14 L | ₹3 L | ₹18 L | ₹37 L | ₹56 L | ₹70 L | ₹6 L | ₹4 L | ₹52 L |
| ₹23 Cr | ₹21 Cr | ₹17 Cr | ₹24 Cr | ₹26 Cr | ₹24 Cr | ₹21 Cr | ₹21 Cr | ₹18 Cr | ₹18 Cr | ₹22 Cr | ₹24 Cr | ₹16 Cr | ₹13 Cr | ₹15 Cr | ₹18 Cr | ₹17 Cr | ₹29 Cr | ₹19 Cr | ₹22 Cr | ₹22 Cr | ₹15 Cr | ₹21 Cr | ₹30 Cr |
| ₹22 Cr | ₹20 Cr | ₹16 Cr | ₹21 Cr | ₹23 Cr | ₹22 Cr | ₹19 Cr | ₹20 Cr | ₹18 Cr | ₹18 Cr | ₹21 Cr | ₹23 Cr | ₹16 Cr | ₹13 Cr | ₹26 Cr | ₹30 Cr | ₹28 Cr | ₹34 Cr | ₹27 Cr | ₹27 Cr | ₹24 Cr | ₹20 Cr | ₹23 Cr | ₹26 Cr |
| ₹2 Cr | ₹1 Cr | ₹86 L | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹35 L | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹8 L | -₹9 L | -₹8 Cr | -₹9 Cr | -₹9 Cr | -₹4 Cr | -₹6 Cr | -₹4 Cr | ₹33 L | -₹4 Cr | -₹62 L | ₹6 Cr |
| ₹21 L | ₹9 L | ₹16 L | ₹28 L | ₹30 L | ₹26 L | ₹28 L | ₹32 L | ₹16 L | ₹27 L | ₹21 L | ₹19 L | ₹17 L | ₹18 L | ₹75 L | ₹63 L | ₹62 L | ₹84 L | ₹74 L | ₹75 L | ₹76 L | ₹74 L | ₹78 L | ₹80 L |
| ₹1 Cr | ₹61 L | ₹30 L | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹94 L | ₹96 L | -₹21 L | ₹30 L | ₹60 L | ₹1 Cr | -₹53 L | -₹71 L | -₹11 Cr | -₹12 Cr | -₹11 Cr | -₹7 Cr | -₹9 Cr | -₹7 Cr | -₹2 Cr | -₹6 Cr | -₹3 Cr | ₹3 Cr |
| ₹1 Cr | ₹61 L | ₹30 L | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹94 L | ₹96 L | -₹21 L | ₹30 L | ₹58 L | ₹1 Cr | -₹53 L | -₹71 L | -₹9 Cr | -₹8 Cr | -₹9 Cr | -₹6 Cr | -₹7 Cr | -₹5 Cr | -₹1 Cr | -₹17 Cr | -₹3 Cr | ₹3 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| — | — | — | — | — | — |
| ₹29 Cr | ₹29 Cr | ₹26 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
| ₹93 Cr | ₹69 Cr | ₹39 Cr | ₹49 Cr | ₹63 Cr | ₹54 Cr |
| ₹93 Cr | ₹69 Cr | ₹39 Cr | ₹49 Cr | ₹63 Cr | ₹54 Cr |
| ₹123 Cr | ₹98 Cr | ₹66 Cr | ₹74 Cr | ₹87 Cr | ₹79 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹47 Cr | ₹0 |
| ₹1 Cr | ₹13 L | ₹0 | ₹0 | ₹9 Cr | ₹14 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | -₹1 Cr | ₹3 Cr |
| ₹1 Cr | ₹2 Cr | ₹89 L | ₹1 Cr | ₹1 Cr | ₹10 L |
| ₹1 Cr | ₹88 L | ₹93 L | ₹1 Cr | ₹2 Cr | ₹2 Cr |
| ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹11 Cr | ₹19 Cr |
| — | — | — | — | — | — |
| ₹11 Cr | ₹14 Cr | ₹15 Cr | ₹23 Cr | ₹28 Cr | ₹31 Cr |
| ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹9 Cr | ₹18 Cr |
| ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹6 Cr | ₹11 Cr | ₹14 Cr |
| ₹1 Cr | ₹95 L | ₹64 L | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| ₹22 Cr | ₹23 Cr | ₹23 Cr | ₹33 Cr | ₹49 Cr | ₹64 Cr |
| ₹148 Cr | ₹124 Cr | ₹90 Cr | ₹110 Cr | ₹195 Cr | ₹162 Cr |
| ₹123 Cr | ₹76 Cr | ₹71 Cr | ₹20 Cr | ₹24 Cr | ₹7 Cr |
| ₹7 Cr | ₹6 Cr | ₹5 Cr | ₹6 Cr | ₹24 Cr | ₹31 Cr |
| — | — | — | — | — | — |
| ₹26 Cr | ₹25 Cr | ₹23 Cr | ₹23 Cr | ₹143 Cr | ₹133 Cr |
| ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹8 Cr | ₹33 Cr | ₹26 Cr |
| ₹15 Cr | ₹14 Cr | ₹14 Cr | ₹15 Cr | ₹110 Cr | ₹108 Cr |
| ₹1 Cr | ₹0 | ₹0 | ₹0 | ₹15 Cr | ₹68 L |
| ₹92 Cr | ₹74 Cr | ₹43 Cr | ₹64 Cr | ₹6 L | ₹2 L |
| ₹92 Cr | ₹74 Cr | ₹43 Cr | ₹64 Cr | ₹6 L | ₹2 L |
| ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹8 Cr | ₹3 Cr |
| ₹14 L | ₹9 L | ₹13 L | ₹17 L | ₹22 L | ₹31 L |
| ₹111 Cr | ₹90 Cr | ₹59 Cr | ₹82 Cr | ₹133 Cr | ₹112 Cr |
| — | — | — | — | — | — |
| ₹11 Cr | ₹9 Cr | ₹10 Cr | ₹11 Cr | ₹28 Cr | ₹24 Cr |
| ₹16 Cr | ₹20 Cr | ₹16 Cr | ₹13 Cr | ₹18 Cr | ₹14 Cr |
| ₹8 Cr | ₹1 Cr | ₹69 L | ₹1 Cr | ₹4 Cr | ₹2 Cr |
| ₹53 L | ₹1 Cr | ₹2 Cr | ₹40 L | ₹2 Cr | ₹65 L |
| ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹11 Cr | ₹8 Cr |
| ₹37 Cr | ₹34 Cr | ₹31 Cr | ₹28 Cr | ₹61 Cr | ₹47 Cr |
| ₹16 Cr | ₹11 Cr | ₹8 Cr | -₹5 Cr | ₹12 Cr | -₹16 Cr |
| ₹148 Cr | ₹124 Cr | ₹90 Cr | ₹110 Cr | ₹195 Cr | ₹162 Cr |
| ₹42 | ₹33 | ₹25 | ₹30 | ₹35 | ₹32 |
| ₹42 | ₹33 | ₹25 | ₹30 | ₹35 | ₹32 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| ₹25 Cr | -₹10 Cr | -₹20 Cr | -₹38 Cr | -₹24 Cr | -₹9 Cr |
| -₹17 Cr | ₹14 Cr | ₹23 Cr | ₹13 Cr | ₹11 Cr | ₹10 Cr |
| ₹2 Cr | -₹3 Cr | -₹13 Cr | ₹11 Cr | -₹24 Cr | ₹7 Cr |
| ₹9 Cr | ₹2 Cr | -₹10 Cr | -₹14 Cr | -₹37 Cr | ₹9 Cr |
| ₹9 Cr | ₹3 Cr | -₹10 Cr | -₹14 Cr | -₹37 Cr | ₹4 Cr |
| -₹3 Cr | -₹45 Cr | ₹18 L | ₹49 L | -₹25 Cr | -₹5 Cr |
| ₹17 L | ₹42 Cr | ₹10 Cr | ₹11 Cr | ₹64 Cr | ₹1 Cr |
| ₹7 Cr | -₹8 L | ₹10 L | -₹3 Cr | ₹2 Cr | ₹49 L |
| ₹4 L | ₹13 L | ₹2 L | ₹3 Cr | ₹88 L | ₹40 L |
| ₹7 Cr | ₹4 L | ₹13 L | ₹2 L | ₹3 Cr | ₹88 L |
Fundamental Ratios
Consolidated
Standalone
No results found
Brooks Laboratories Share Price
67.25+2.69 (+4.17%)
-39.92% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 3 out of 9 oscillators
RSI
57.94Buy
STOCH %K
65.64Neutral
MACD Level(12,26)
0.43Buy
Ultimate Oscillator
44.61Sell
Aroon Oscillator
10.00Sell
BOP
0.52Buy
CCI
53.19Neutral
Williams %R
-34.36Neutral
Momentum
-1.47Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 8
Bearish signals: 1 out of 9 moving averages
EMA 9
63.35Buy
SMA 9
61.67Buy
EMA 21
62.75Buy
SMA 21
63.67Buy
EMA 50
62.69Buy
SMA 50
62.66Buy
EMA 200
71.77Sell
SMA 200
63.21Buy
WMA 20
63.10Buy
Pivot
Pivot
Classic
Resistance 5
81.42
Resistance 4
77.38
Resistance 3
73.34
Resistance 2
69.30
Resistance 1
66.93
Pivot
65.26
Support 1
62.89
Support 2
61.22
Support 3
57.18
Support 4
53.14
Support 5
49.10
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Brooks Laboratories Share Price
67.25+2.69 (+4.17%)
-39.92% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 52.62% | 52.62% | 52.62% | 52.62% | 52.62% | 52.62% |
| 0.04% | 0.00% | 0.17% | 0.09% | 0.01% | 0.00% |
| 0.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 9.90% | 9.90% | 9.90% | 9.90% | 9.90% | 9.90% |
| 37.32% | 37.48% | 37.31% | 37.39% | 37.47% | 37.48% |
Bulk & block deals
Name
Amit Kumar Jain
Amit Kumar Jain
Ramesh Thakurdas Jaisinghani
Aryan Mahajan
Rr Family Trust
Atul Ranchal
Atul Ranchal
One Up Financial Consultants Pvt Ltd
Saravana Global Holdings Limited
Mukul Maheshwari (Huf)
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 08 Oct 2026 | Purchase | 1.81 Cr | ₹70.26 | 2.58 L | Bulk | 0.87599 | NSE |
| 08 Oct 2026 | Sell | 1.95 Cr | ₹70.24 | 2.78 L | Bulk | 0.943953 | NSE |
| 08 May 2026 | Sell | 86.34 L | ₹50.55 | 1.71 L | Bulk | 0.579834 | NSE |
| 14 Nov 2024 | Sell | 6.60 Cr | ₹137.40 | 4.80 L | Bulk | 1.629483 | BSE |
| 14 Nov 2024 | Purchase | 3 Cr | ₹137.40 | 2.18 L | Bulk | 0.741075 | BSE |
| 14 Nov 2024 | Sell | 2.75 Cr | ₹137.40 | 2 L | Bulk | 0.678951 | BSE |
| 14 Nov 2024 | Sell | 5.39 Cr | ₹136.40 | 3.95 L | Bulk | 1.340966 | NSE |
| 14 Nov 2024 | Purchase | 5.46 Cr | ₹136.40 | 4 L | Bulk | 1.357902 | NSE |
| 16 May 2024 | Sell | 1.27 Cr | ₹92.12 | 1.38 L | Bulk | 0.469827 | NSE |
| 21 Apr 2022 | Purchase | 1.38 Cr | ₹104.67 | 1.32 L | Bulk | 0.44694 | NSE |
Insider trading & SAST
Client name
Aryan Mahajan
Atul Ranchal & Pacs
Saras Gupta
Atul Ranchal
Atul Ranchal
Atul Ranchal
Saras Gupta
Aryan Mahajan
Savvy Ranchal
Selina Ranchal
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22 Nov 2024 | Promoter | Disposal | 1.83 | 2.77 | 0 | — | 4.80 L | 14 Nov 2024 | Market | 7,26,490 | SAST | 29(2) | — |
| 22 Nov 2024 | Promoter | Disposal | 4.54 | 59.06 | 0 | — | 11.90 L | 14 Nov 2024 | Market | 1,55,00,292 | SAST | 29(2) | — |
| 22 Nov 2024 | Promoter | Disposal | 0.44 | 2.63 | 0 | — | 1.15 L | 14 Nov 2024 | Market | 6,90,143 | SAST | 29(2) | — |
| 22 Nov 2024 | Promoter | Disposal | 2.27 | 21.6 | 0 | — | 5.95 L | 14 Nov 2024 | Market | 56,68,060 | SAST | 29(2) | — |
| 17 Nov 2024 | Promoter | Disposal | 0.762001 | 21.6 | 2.75 Cr | ₹137.40 | 2 L | 14 Nov 2024 | Market Sale | 56,68,060 | Insider Trading | — | Equity Shares |
| 17 Nov 2024 | Promoter | Disposal | 1.504993 | 22.36 | 5.39 Cr | ₹136.40 | 3.95 L | 14 Nov 2024 | Market Sale | 58,68,060 | Insider Trading | — | Equity Shares |
| 17 Nov 2024 | Promoter Group | Disposal | 0.43969 | 2.63 | 1.59 Cr | ₹137.40 | 1.15 L | 14 Nov 2024 | Market Sale | 6,90,143 | Insider Trading | — | Equity Shares |
| 17 Nov 2024 | Promoter Group | Disposal | 1.828801 | 2.77 | 6.60 Cr | ₹137.40 | 4.80 L | 14 Nov 2024 | Market Sale | 7,26,490 | Insider Trading | — | Equity Shares |
| 31 Aug 2023 | Promoter Group | Acquisition | 0.346527 | 3 | 9.10 L | ₹10 | 90.95 K | 30 Aug 2023 | Public Right | 7,87,252 | Insider Trading | — | Equity Shares |
| 31 Aug 2023 | Promoter Group | Acquisition | 0.178567 | 1.55 | 4.69 L | ₹10 | 46.87 K | 30 Aug 2023 | Public Right | 4,05,668 | Insider Trading | — | Equity Shares |
Brooks Laboratories Share Price
67.25+2.69 (+4.17%)
-39.92% past 1 Year
Brooks Laboratories Limited (Brooks Laboratories) is a pharmaceutical contract research and manufacturing services company. It provides range of products catering to critical care segment in Parental Section, such as Beta
Corporate Actions
Date
Type
Details
Company details
Brooks Laboratories Share Price
67.25+2.69 (+4.17%)
-39.92% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
No presentations found
Brooks Laboratories Share Price
67.25+2.69 (+4.17%)
-39.92% past 1 Year
News
Brooks Laboratories informs about trading window closure
Equity
BROOKS
Brooks Laboratories informs about newspaper publication
Equity
BROOKS
Brooks Laboratories reports Profit after tax of 30.30 Lakhs, in the December 2025 quarter
Equity
BROOKS
Brooks Laboratories reports Profit after tax of 2.24 Crores, in the September 2025 quarter
Equity
BROOKS
Brooks Laboratories - Quaterly Results
Equity
BROOKS
Brooks Laboratories reports Profit after tax of 72.40 Lakhs, in the December 2024 quarter
Equity
BROOKS
Brooks Laboratories - Quaterly Results
Equity
BROOKS
Brooks Laboratories: Co Approves Fund Raise Of Up To 75.00 Crores Rupees || Fund Raise Through Issue Of Equity Shares On Preferential Basis
Equity
BROOKS
Brooks Laboratories - Quaterly Results
Equity
BROOKS
Brooks Laboratories reports Profit after tax of Rs -21.20 Lakhs, in the June 2024 quarter
Equity
BROOKS
Brooks Laboratories - Quaterly Results
Equity
BROOKS
Brooks Laboratories - Quaterly Results
Equity
BROOKS
Brooks Laboratories - Quaterly Results
Equity
BROOKS
Brooks Laboratories reports Profit after tax of 57.70 Lakhs, in the December 2023 quarter
Equity
BROOKS
Brooks Laboratories informs about board meeting
Equity
BROOKS
Brooks Laboratories: Board Meeting On Jan 24 To Consider And Approve Fund Raising Through Rights Issue
Equity
BROOKS
Brooks Laboratories: Co Says Fixed 11.58 Crores Rupees As Right Issue Size || Right Issue Price At 75 Rupees Per Share
Equity
BROOKS
Brooks Laboratories informs about resignation of director
Equity
BROOKS
Brooks Laboratories reports Profit after tax of Rs -72.10 Lakhs, in the March 2023 quarter
Equity
BROOKS
Brooks Laboratories informs about clarification
Equity
BROOKS